Previous 10 | Next 10 |
home / stock / imexf / imexf news
VANCOUVER, British Columbia and BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the launch of new social media campaigns via Twitter, Fa...
VANCOUVER, British Columbia and BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met with the U.S. Food and Drug Administration (...
VANCOUVER, British Columbia and BOSTON, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the three months ended June 30, 2019. All ...
VANCOUVER, British Columbia and BOSTON, July 15, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress toward verification of its i/Blue functional ...
VANCOUVER, British Columbia and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that, under its stock option plan, it has granted incentive stock options to a consultant of th...
Imagin Medical ( OTCQB:IMEXF ): Q2 GAAP EPS of -C$0.01. More news on: Imagin Medical Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
VANCOUVER, British Columbia and BOSTON, June 11, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the three months ended March 31, 2019. All...
VANCOUVER, British Columbia and BOSTON, June 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development and commercialization of advanced medica...
VANCOUVER, British Columbia and BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that Dr. Ashish M. Kamat has joined its Scientific Advisory Bo...
VANCOUVER, British Columbia and BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it reached the first step of a major product development ...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET Surgical imaging for bladder cancer Imagin Medical is a surgical imaging company. They're focusing on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The Company’s initially focused on bladder ca...
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin PR Newswire Ponce Therapeutic's (" Ponce ") lead product, ReBea...
Imagin Medical Announces Stock Option Grants PR Newswire VANCOUVER , BC and BOSTON , April 22, 2022 /PRNewswire/ -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) ( Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today...